Sleep problems are becoming increasingly prevalent among adolescents, rising from 31.2% in 2003 to 41.9% in 2012 ([@b1-prm-19-e139]). Such problems are characterized as poor sleep hygiene and, in particular, difficulties initiating or maintaining sleep. Negative perceptions of sleep, such as rumination over bad sleep quality, are also likely to arise from these difficulties. There is a growing body of evidence to suggest that childhood sleep problems may precipitate difficulties later in life, specifically musculoskeletal pain ([@b2-prm-19-e139]--[@b4-prm-19-e139]). The present study aimed to explore the association, if any, between sleep problems and the presence of musculoskeletal pain in a large adolescent cohort.

Both sleep quality and quantity undergo significant changes during adolescence due to the increased risk of sleep disturbance during this period. Specifically, adolescents rarely sleep for the recommended 9 h to 10 h per night, and instead exhibit a higher incidence of sleep supplementation (eg, daytime napping) ([@b5-prm-19-e139]). Other problems include a greater number of wakes per night, longer sleep onset latencies (\>30 min) and dramatic shifts in sleep-wake schedules across the week ([@b6-prm-19-e139],[@b7-prm-19-e139]). Such disturbances significantly disrupt the homeostatic sleep-wake cycle, which causes excessive sleepiness and ultimately affects behavioural, cognitive and emotional functioning ([@b8-prm-19-e139],[@b9-prm-19-e139]).

Sleep and pain share a complex, reciprocal relationship: pain can disrupt sleep and, conversely, poor sleep can exacerbate pain intensity ([@b10-prm-19-e139],[@b11-prm-19-e139]). Sleep problems have long been linked to musculoskeletal pain ([@b12-prm-19-e139]) and, in particular, chronic widespread pain (CWP). Longitudinal studies in adult populations have found sleep problems to be predictive of CWP and disorders such as fibromyalgia ([@b13-prm-19-e139],[@b14-prm-19-e139]). Similar studies also found that good-quality restorative sleep was more likely to predict the resolution of pain symptoms and the subsequent return to musculoskeletal health in patients with CWP ([@b15-prm-19-e139]). Currently, little is known about the role of sleep in adolescent pain populations such as those with juvenile fibromyalgia.

The prevalence of musculoskeletal pain in adolescence is estimated to be approximately 4% to 40% ([@b16-prm-19-e139]). The development of musculoskeletal pain during this time could have significant ramifications for an adolescent's developmental trajectory, impacting an adolescent's physical, emotional and social well-being. Adolescents may miss school and have reduced engagement with social and recreational activities. Chronic musculoskeletal pain also poses a significant developmental health concern in terms of a child's mental health, impacting negatively on mood, somatic internalization and attentional factors ([@b17-prm-19-e139]). It is, therefore, critical that any potential risk factors are identified in early childhood.

Problematic sleep has been found to increase pain sensitivity and facilitate pain episodes in both animal and adult populations ([@b11-prm-19-e139],[@b18-prm-19-e139],[@b19-prm-19-e139]). A growing body of evidence suggests that sleep problems pose an important risk for the development of musculoskeletal pain in adolescents. A large cross-sectional study involving 6986 adolescents found short sleep time to be a risk factor associated with regional musculoskeletal pain ([@b20-prm-19-e139]). A prospective four-year study followed children with musculoskeletal pain from 10 to 14 years of age and found tiredness and difficulty falling asleep to be predictive factors of recurrent pain ([@b2-prm-19-e139]). Similarly, another longitudinal study involving 1773 adolescents identified insufficient sleep at 16 years of age as a risk factor for the development of neck and lower back pain in girls at 18 years of age ([@b21-prm-19-e139]). Finally, factors such as daytime hypersomnolence and sleep disturbance are also associated with an increased likelihood of developing chronic musculoskeletal pain ([@b4-prm-19-e139]). Such studies complement longitudinal studies from adult cohorts suggesting that late-onset insomnia can predict both the development of a pain condition and pain severity ([@b22-prm-19-e139],[@b23-prm-19-e139]).

Previous studies have focused mainly on localized or regional pain; therefore, the determinants of widespread musculoskeletal pain are not well known. Importantly, we need to better understand the role of sleep in widespread pain conditions such as juvenile fibromyalgia. The present study had two aims. First, we sought to explore the prevalence of chronic regional pain (CRP) and CWP in a large birth cohort. Second, by using fibromyalgia definitions to identify those with CWP, we sought to explore which characteristics of sleep were associated with such pain outcomes. Specifically, we explored the association between a variety of sleep problems at 15 years of age (eg, disturbance, hypersomnolence) and both CRP and CWP at 17 years of age. We hypothesised that subjective sleep problems at 15 years of age would be associated with musculoskeletal pain and increased pain severity at 17 years of age.

METHODS
=======

Participants
------------

The Avon Longitudinal Study of Parents and Children (ALSPAC) ([@b24-prm-19-e139]) is a prospective population-based study investigating a wide range of genetic and environmental influences on the health and development of children. Between April 1, 1991 to December 31, 1992, 14,541 pregnant women were initially enrolled from the district formerly known as Avon (United Kingdom). A total of 14,062 children were born and 13,988 were alive at 12 months of age. The main focus of the present study was the results obtained from research clinics held at 15 and 17 years of age. A total of 5509 children attended the research clinic at 15 years of age and 5102 attended at 17 years of age. For the variables of interest, a complete data set was available for 2493 participants. Given that data were only available for 45% of individuals who attended the clinic at 15 years of age, χ^2^ tests were used to establish whether there were any differences in the variables of interest between those with and without data. Analyses showed that the groups differed according to sex (χ^2^\[1\]=57.53; P\<0.001) and socioeconomic status (χ^2^\[6\]=41.15, P\<0.001). The flow chart ([Figure 1](#f1-prm-19-e139){ref-type="fig"}) shows the selection of adolescents who comprised the final sample for analysis. Ethics approval for the study was obtained from the ALSPAC Ethics and Law Committee and the local Research Ethics Committees.

Pain questionnaire
------------------

The pain questionnaire was administered to all participants attending a research clinic at 17 years of age. Based on combinations of pain previously reported in the literature, the questionnaire was assembled from domains and scales taken from previously validated questionnaires ([@b25-prm-19-e139]-[@b27-prm-19-e139]). The questionnaire covered three aspects of pain: the experience of localized pain, the overall experience of pain and the impact of pain on aspects of life.

Initially, participants indicated whether they had experienced any aches or pains that had lasted for longer than one day in the past month and, if so, whether this had started in the past three months, or before. Using a mannequin, they were asked to indicate the site of the pain. Participants were then provided with a list of regions (eg, shoulder, knee) and asked to indicate whether they had experienced no pain or pain ranging from not at all to slightly, moderately, very or extremely troubling. Choosing their most troublesome pain, they were asked to indicate whether, over the past three to six months, their pain had lasted for \<7 days, one to four weeks, one to three months or ≥3 months. Finally, as part of the Chronic Pain Grade Questionnaire ([@b27-prm-19-e139]) participants were asked to rate their average pain severity over the past six months on a scale of 1 (no pain at all) to 10 (worst pain imaginable). Only 1147 (46.0%) of the adolescents completed this final measure.

Based on the participants' experience of chronic pain (pain lasting ≥3 months) variables were derived from pain patterns consistent with clinical phenotypes and, in particular, musculoskeletal pain ([@b28-prm-19-e139]). Two forms of musculoskeletal pain were identified: CRP and CWP. CRP comprised of moderately, very or extremely troublesome pain lasting \>3 months affecting the knee, hip, shoulder, lower back or a combination of these sites, as indicated by completion of the troublesome pain domain. CWP was based on diagnostic criteria for fibromyalgia (ie, pain on both sides of the body, above and below the waist and in the axial skeleton that has been present for ≥3 months), based on completion of the pain mannequin ([@b29-prm-19-e139]). Specifically, CWP comprised of pain lasting \>3 months, axial pain and upper left quadrant pain plus lower right quadrant pain (or vice versa), as assessed by completion of the pain mannequin. These definitions for both the CRP and CWP phenotypes were consistent with guidelines outlined by the American College of Rheumatology and have previously been used to assess musculoskeletal pain in a large population study ([@b28-prm-19-e139]). Unfortunately, no pain measures were administered before the 17 years of age clinic.

Sleep problems
--------------

The participants had previously attended a research clinic at 15 years of age, at which they completed a sleep questionnaire that assessed aspects of their sleep pattern. Initially, participants were asked to rate whether they considered themselves to be a 'good' or a 'poor' sleeper. Sleep disturbance was assessed by asking participants how many times a night they usually woke up, to which they could answer: never, once, two or three times or \>3 times. Hypersomnolence was also assessed by asking the children how much of a problem they had with sleepiness during daytime activities (eg, feeling sleepy, struggling to stay awake): no problem, a little problem, more than a little problem, a big problem and a very big problem. Finally, participants were asked to rate the perceived quantity of their sleep by rating how often they believed they got enough sleep: always, usually, sometimes, rarely, never. Due to the low number of observations within some response categories, certain questionnaire items were collapsed before analysis. For example, the responses 'rarely' and 'never' were combined into one category for the quantity question. These ordered response categories were collapsed so that a sufficient number of observations were included in each level of the logistic regression model. Levels were only collapsed if it was theoretically viable to do so, and subsequent analyses were examined to ensure that the models did not differ drastically. This was also performed for both the disturbance (two or three times/\>3 times) and hypersomnolence (big problem/very big problem) questions. Overall, reliability of the sleep questionnaire found to be acceptable (Cronbach's α=0.67). To assess which characteristics of sleep were associated with musculoskeletal pain, each item was examined independently.

Sleep data was also collected at the 17 years of age clinic using a computerized version of the Clinical Interview Schedules -- Revised (CIS-R). The interview is fully standardized and equally reliable whether conducted by a clinically trained interviewer or self-administered via a computer ([@b30-prm-19-e139]--[@b32-prm-19-e139]). The CIS-R is designed for and has been widely used within adolescent birth cohorts including National Surveys of Psychiatric Morbidity and the 1958 birth cohort ([@b32-prm-19-e139]--[@b34-prm-19-e139]). The CIS-R has 14 subsections, including an assessment of sleep problems. Specifically, the interview examines changes in sleep patterns, causes of sleep disturbance and duration of sleep to assess the severity of the sleep problem. Each subsection has a score of between zero and four, and a symptom with a score of ≥2 should be considered a significant sleep problem. This criterion was used to identify adolescents with an identifiable sleep problem.

Other measures
--------------

Previous studies have found that both background factors (ethnicity, sex, socioeconomic status) and emotional factors are associated with recurrent pain across adolescence ([@b35-prm-19-e139]--[@b37-prm-19-e139]). To control for the potential influence from these factors, they were entered as covariates into the regression models. Specifically, depression was assessed using the Development and Well-Being Assessment when children were 15 years of age. This assessment is a self-report measure that inquires about psychiatric symptoms to generate *International Classification of Diseases -- 10th Revision* diagnoses ([@b38-prm-19-e139]). The semistructured interview includes both open and closed questions about a range of symptoms related to childhood depression. The responses provide a likely diagnosis of depression where appropriate. Socioeconomic position indicators were obtained from self-administered questionnaires to the mothers. Social class was defined using the UK Registrar General's occupational coding (SOC 90) and grouped into six categories : I, professional; II, managerial and technical; III, skilled manual or non-manual; IV, semiskilled manual; V, unskilled; VI, armed forces. The highest social class of either expectant parent was used to define parental social class. Sex and ethnicity were also recorded.

Data analysis
-------------

The relationship between sleep problems (15 years of age) and the presence of musculoskeletal pain (17 years of age) was examined using logistic regression. ORs were calculated for an unadjusted model, a model partially adjusted for sex, ethnicity and socioeconomic position and, finally, a fully adjusted model additionally controlling for depression at 15 years of age and current sleep problems (17 years of age). Specifically, associations between independent measures of sleep (subjective perception, hypersomnolence, disturbance and perceived quantity) at 15 years of age, and CWP and CRP at 17 years of age were analyzed. Ordered logistic regression was used to assess the influence of sleep problems on pain severity in those reporting CRP and CWP. Pain severity scores were initially scored on a 1 to 10 ordinal scale. Responses were categorized into three groups: no pain to mild pain ([@b1-prm-19-e139]--[@b4-prm-19-e139]), moderate pain ([@b5-prm-19-e139]--[@b7-prm-19-e139]) and severe pain ([@b8-prm-19-e139]--[@b10-prm-19-e139]). Specifically, pain severity was tested in individuals who considered themselves good and poor sleepers. All statistical analyses were conducted using Stata 12. The study website contains details of all the data that are available through a fully searchable data dictionary ([@b38-prm-19-e139],[@b39-prm-19-e139]).

RESULTS
=======

The sample was predominantly female (n=1456 \[58.4%\]) and of European ancestry (98.2%) For full demographic information, see [Table 1](#t1-prm-19-e139){ref-type="table"}. CRP was identified in 116 (4.7%) of those sampled and 101 (4.1%) were identified as having CWP. Both CRP and CWP were observed in 29 participants (1.2%). Only 10.7% (n=269) reported that they felt that they always had enough sleep. A total of 38.7% (n=965) described not having any difficulties with hypersomnolence. More than one-half of the sample (n=1408 \[56.5%\]) reported never having problems with waking up during the night. Finally, 15.2% (n=379) of the sample considered themselves to be poor sleepers. Full sleep characteristics of those with and without musculoskeletal pain are presented in [Table 2](#t2-prm-19-e139){ref-type="table"}.

Nearly one-half of the sample (n=1138 \[45.6%\]) indicated 'yes' to having pain lasting for longer than one day in the past month. Eighteen of these however, failed to complete the pain mannequin. Of the remaining 1130, nearly one-half (n=481 \[42.5%\]) stated that the pain had been troublesome for less than seven days, while 293 (25.9%) reported it had bothered them for between one and four weeks. Fewer individuals reported having troublesome pain lasting between one and three months (n=185 \[16.4%\]) and 171 (15.1%) had experienced troublesome pain for \>3 months. The mean (± SD) pain severity (out of 10) in the CRP group was 5.64±2.21 and 5.38±2.35 in the CWP group.

The relationship between sleep problems at 15 years of age and musculoskeletal pain at 17 years of age was examined using logistic regression ([Tables 3](#t3-prm-19-e139){ref-type="table"} and [4](#t4-prm-19-e139){ref-type="table"}). OR were calculated after adjusting for sex, ethnicity, socioeconomic status, depression at 15 years of age and current sleep problems at 17 years of age. Sleep disturbance (usually wakes more than two or three times) was associated with increased odds of both CRP (OR 1.81 \[95% CI 1.07 to 3.07\]) and CWP (OR 2.13 \[95% CI 1.22 to 3.74\]). Those who considered themselves to be 'poor sleepers' also had greater odds of developing CRP (OR 1.61 \[95% CI 1.01 to 2.58\]) and CWP (OR 1.77 \[95% CI 1.07 to 2.91\]). Those reporting big to very big difficulties with hypersomnolence were associated with CRP (OR 3.42 \[95% CI 1.62 to 7.22\]) and CWP (OR 2.76 \[95% CI 1.05 to 7.25\]). Finally, perceived quantity of sleep was only associated with CRP (OR 3.04 \[95% CI 1.18 to 7.79\]).

Ordered logistic regression was used to assess the association between sleep and pain severity in those reporting CRP and CWP, in those with available data (n=1147). Pain severity was ordered into the following categories: no pain to mild pain, moderate pain and severe pain. Problematic sleep was associated with greater pain severity in participants with both CRP (n=115; OR 2.78 \[95% CI 1.23 to 6.29\]) and CWP (n=100; OR 2.46 \[95% CI 1.03 to 5.88\]). The results suggest that subjective perceptions of being a 'poor sleeper' are associated with greater levels of musculoskeletal pain severity.

DISCUSSION
==========

As hypothesized, our results are suggestive of an association between sleep problems during adolescence and musculoskeletal pain at a later time point. Poor subjective perceptions of sleep, states of hypersomnolence and higher degrees of disturbance were associated with the presence of CRP and CWP. Furthermore, for individuals experiencing musculoskeletal pain, participants describing themselves as poor sleepers at 15 years of age reported greater pain severity at 17 years of age.

Our results complement the previous literature showing an association between sleep problems and chronic musculoskeletal pain conditions. Studies of a Finnish cohort have found both hypersomnolence ([@b40-prm-19-e139]) and sleep disturbance to predict the development of musculoskeletal problems ([@b2-prm-19-e139]). A later study also found that both insufficient sleep quality and quantity were independent risk factors for the development of neck and lower back pain in females ([@b21-prm-19-e139]). Given this mounting evidence, it appears that poor sleep is indeed a potential risk factor for the development of musculoskeletal pain.

When one considers Lewin and Dahl's ([@b41-prm-19-e139]) proposed model of sleep problems and chronic pain in adolescence, it is possible to speculate on mechanisms whereby sleep problems can contribute to the development of musculoskeletal pain. Sleep disturbance can lay the foundations for a number of neurophysiological changes that can alter pain thresholds including increased sensitivity ([@b18-prm-19-e139],[@b19-prm-19-e139]). Not only does sleep influence brain maturation, but it also supports a number of biological and neurophysiological changes that occur during adolescence. Of particular importance are the effects that sleep disruption can have on the opioidergic system, immune and endocrinological processes. Dysfunctions in each of these systems have been linked to CWP ([@b42-prm-19-e139]--[@b45-prm-19-e139]). While it is outside the scope of the present article to discuss these systems, it is possible to recognize how sleep problems may make adolescents neurophysiologically more vulnerable to the development of chronic illness, and in particular CRP and CWP.

Given that pain data were not available at 15 years of age, it is difficult to rule out the possibility that the adolescents had existing musculoskeletal difficulties. Nonetheless, the finding of greater pain severity in those with CRP and CWP who considered themselves poor sleepers was of particular interest. Previous studies have shown how negative perceptions of sleep (eg, ruminating over poor sleep quality) can influence pain severity in both adolescent and adult pain populations ([@b12-prm-19-e139],[@b46-prm-19-e139]). Such findings are relevant to the proposal that problematic sleep makes us more cognitively vulnerable to the detrimental psychological aspects of experiencing both acute and chronic pain ([@b41-prm-19-e139]). States of hypersomnolence can result from acute sleep loss, reducing both cognitive acuity and the drive to initiate behaviours or seek rewards. Emotional changes, such as low mood or frustration, are also observed in individuals who are sleep deprived ([@b47-prm-19-e139]). Such factors may reduce long-term pain-related rehabilitation goals.

Acute sleep loss can lead to attentional deficits such as impairments with sustained attention, vigilance and cognitive flexibility. In particular, individuals who are sleep deprived show a diminished capacity to exert control over their attentional focus ([@b48-prm-19-e139]). This means the ability to divert or reorientate attention away from sources of threat may be undermined and may indirectly contribute to increased pain severity. This, over time, may cause one to become hypervigilant to the threat of pain, meaning individuals will avoid particular activities that are perceived to cause pain. This can lead to a disability-enhancing cycle, whereby those with sleep problems become more sedentary due to the increased threat of pain and reduced motivation which, therefore, reduces the likelihood of rehabilitation. Such factors may explain the association between early sleep problems and later comorbid musculoskeletal pain and sleep problems.

Although the complexity of the sleep-pain relationship in paediatric pain populations has been acknowledged ([@b41-prm-19-e139],[@b49-prm-19-e139]), we need to develop a better understanding of biopsychosocial factors related to sleep and pain. Studies objectively measuring the effects of sleep in adolescents have reported mixed findings ([@b50-prm-19-e139]--[@b52-prm-19-e139]). Further research using larger sample sizes and polysomographic measures are required to objectively test the findings from large epidemiological studies.

Although the present study has revealed some interesting associations, there are limitations to the interpretation of the results. First, because pain measures were not available at 15 years of age, it is difficult to rule out the possibility that the participants were already experiencing a pain-related illness. Second, both forms of musculoskeletal pain are likely to be associated with several comorbid developmental problems, and it may be impossible to separate them. The present study attempted to control for a number of these factors but early childhood influences could also have residual effects. Third, we must be cautious of overinterpreting the results, given that subjective self-report measures were used to ascertain information about the adolescents' sleep patterns. In particular, care must be taken when interpreting the subjective perception of sleep given how they were assessed; for example, the metric assessing 'sleep disturbance' does not provide us with a quantitative index of sleep disturbance. Furthermore, different measures were used to assess sleep at the two time points; however, both provided suitable indexes of problematic sleep. Objective, longitudinal and translational studies are needed to elucidate the influence of adolescent sleep patterns on brain development, physiological processes and the development of musculoskeletal pain. Despite these limitations, the factors that may be contributing to sleep problems at 15 years of age may play a part in the presence of musculoskeletal pain at 17 years of age.

The low prevalence of both CWP and CRP in our sample must be acknowledged. Given that previous studies have revealed a wide range in the prevalence estimates (4% to 40%) of musculoskeletal pain in adolescence, this may speak to the different measures and scales used to assess musculoskeletal pain. For example, Auvinen et al ([@b21-prm-19-e139]) reported high prevalence estimates of musculoskeletal pain (42% to 52%) based on a dichotomous response to a single item measure. The criterion used for CWP in the present study is consistent with the diagnostic criteria for fibromyalgia. Whereas tenderness on clinical examination (not recorded in present study) is usually included, this has recently been dropped in the revised American College of Rheumatology criteria ([@b53-prm-19-e139]). Our findings could, therefore, have important implications for adolescents with juvenile fibromyalgia. However, both longitudinal and objective measures are required to better establish the role of sleep in such pain populations. Adolescents already face abrupt variations in their sleep pattern because sleep-wake schedules rapidly change across weekdays and weekends. It is especially important to catch sleep problems early in adolescence because sleep disruption is reported to become worse as the teenager moves into young adulthood ([@b7-prm-19-e139]). Modern societies also pose a significant risk factor for prolonged sleep disturbance. For example, increased societal pressures may result in various anxieties, which can impact both sleep onset and continuity. The increased availability of pharmacological stimulants such as caffeine may also mean adolescents get less sleep. Similarly, availability of electronic stimulation, such as television and the Internet (particularly on smartphones), in the bedroom is becoming more commonplace, meaning there is a trend for adolescents to delay sleep, but still wake up for school. Over the decade, sleep restriction or disturbance is only likely to become more prevalent and, unfortunately, problematic.

Our results would suggest that the treatment of sleep problems in adolescents is of clinical relevance. Problematic sleep is associated with both impaired physiological and psychological well-being ([@b54-prm-19-e139]), the consequences of which could be detrimental to an adolescent's emotional, social and educational development. Such maladaptive development could subsequently make adolescents more vulnerable to chronic illness as they progress into adulthood ([@b55-prm-19-e139],[@b56-prm-19-e139]). Dealing with the psychological aspects of problematic sleep may also be beneficial for adolescents with musculoskeletal problems. For example, cognitive behavioural therapy with a focus on sleep was found to be effective in alleviating pain symptoms and improving quality of life in adolescents with musculoskeletal pain conditions ([@b57-prm-19-e139]).

Both sleep problems and, importantly, musculoskeletal pain conditions can cause a deviation in an adolescent's normal developmental trajectory. The present study complements previous research in suggesting that sleep is a modifiable risk factor for musculoskeletal pain. Given the risks associated with sleep problems, sleep should be considered as a potential therapeutic target in both the prevention and management of certain illnesses and, in particular, musculoskeletal conditions.
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###### 

Demographic data for participants with and without musculoskeletal pain

                                                                           **Chronic regional pain**   **Chronic widespread pain**                 
  ------------------------------------------------------------------------ --------------------------- ----------------------------- ------------- -----------
  Female                                                                   1371 (55.0)                 85 (3.4)                      1380 (55.4)   76 (3.1)
  Male                                                                     1006 (40.4)                 31 (1.2)                      1012 (40.6)   25 (1.0)
  Ethnicity                                                                                                                                        
    White                                                                  2334 (93.6)                 114 (4.6)                     2329 (93.4)   99 (4.0)
    Black African                                                          6 (0.2)                     2 (0.1)                       8 (0.3)       0 (0.0)
    Black Caribbean                                                        1 (0.0)                     0 (0.0)                       1 (0.0)       0 (0.0)
    Other Black                                                            2 (0.1)                     0 (0.0)                       2 (0.1)       0 (0.0)
    Indian                                                                 9 (0.4)                     0 (0.0)                       8 (0.3)       1 (0.0)
    Pakistani                                                              1 (0.0)                     0 (0.0)                       1 (0.0)       0 (0.0)
    Chinese                                                                9 (0.4)                     0 (0.0)                       9 (0.4)       0 (0.0)
    Other                                                                  15 (0.6)                    0 (0.0)                       14 (0.6)      1 (0.0)
  Socioeconomic position                                                                                                                           
    Class I                                                                125 (5.1)                   5 (0.2)                       126 (5.1)     4 (0.2)
    Class II                                                               677 (27.2)                  20 (0.8)                      668 (26.8)    29 (1.2)
    Class III                                                              689 (27.6)                  43 (1.7)                      710 (28.5)    22 (0.9)
    Class IV                                                               553 (22.2)                  31 (1.2)                      557 (22.3)    27 (1.1)
    Class V                                                                275 (11.0)                  14 (0.6)                      272 (10.9)    17 (0.7)
    Armed forces                                                           56 (2.3)                    3 (0.1)                       57 (2.3)      2 (0.1)
    Don't know                                                             2 (0.0)                     0 (0.0)                       2 (0.1)       0 (0.0)
  Pain severity^[\*](#tfn2-prm-19-e139){ref-type="table-fn"}^, mean ± SD   4.16±2.07                   5.64±2.21                     4.21±2.08     5.38±2.35

Data presented as n (%) unless otherwise indicated.

Out of 10

###### 

Sleep characteristics of participants with and without musculoskeletal pain

  **Types of sleep disturbance**   **Chronic regional pain**   **Chronic widespread pain**                 
  -------------------------------- --------------------------- ----------------------------- ------------- ----------
  Do you consider yourself a:                                                                              
    Good sleeper                   2026 (81.3)                 88 (3.5)                      2038 (81.7)   76 (3.0)
    Poor sleeper                   351 (14.1)                  28 (1.1)                      354 (14.2)    25 (1.0)
  Usually wakes up:                                                                                        
    Never                          1356 (54.4)                 52 (2.1)                      1367 (54.8)   41 (1.6)
    Once                           719 (28.8)                  40 (1.6)                      722 (29.0)    37 (1.5)
    2--3 times/\>3 times           302 (12.1)                  24 (1.0)                      303 (12.2)    23 (0.9)
  Problems with hypersomnolence:                                                                           
    Never                          916 (36.7)                  49 (2.0)                      934 (37.5)    31 (1.2)
    A little                       1246 (50.0)                 48 (1.9)                      1245 (49.9)   49 (2.0)
    More than a little             166 (6.7)                   8 (0.3)                       159 (6.4)     15 (0.6)
    Big/very big                   49 (2.0)                    11 (0.4)                      54 (2.2)      6 (0.2)
  Enough sleep:                                                                                            
    Always                         263 (10.5)                  6 (0.2)                       257 (10.3)    12 (0.5)
    Usually                        1244 (49.9)                 57 (2.3)                      1258 (50.5)   43 (1.7)
    Sometimes                      618 (24.8)                  30 (1.2)                      622 (24.9)    26 (1.0)
    Rarely/never                   252 (10.1)                  23 (0.9)                      255 (10.2)    20 (0.8)

Data presented as n (%)

###### 

Associations between different forms of sleep problems at 15 years of age and the development of chronic regional pain at 17 years of age

  **Types of sleep disturbance**   **n**   **Unadjusted model**   **Partially adjusted model^[†](#tfn4-prm-19-e139){ref-type="table-fn"}^**   **Fully adjusted model^[‡](#tfn5-prm-19-e139){ref-type="table-fn"}^**                                                                                 
  -------------------------------- ------- ---------------------- --------------------------------------------------------------------------- ----------------------------------------------------------------------- --------------------------------------------------------- ------------------- ---------------------------------------------------------
  Do you consider yourself a:                                                                                                                                                                                                                                                                       
    Good sleeper                   2114    Reference                                                                                          Reference                                                                                                                         Reference           
    Poor sleeper                   379     1.84 (1.18--2.85)      \<0.01^[\*\*](#tfn7-prm-19-e139){ref-type="table-fn"}^                      1.76 (1.13--2.74)                                                       0.01^[\*](#tfn6-prm-19-e139){ref-type="table-fn"}^        1.61 (1.01--2.58)   0.04^[\*](#tfn6-prm-19-e139){ref-type="table-fn"}^
  Usually wakes up:                                                                                                                                                                                                                                                                                 
    Never                          1408    Reference                                                                                          Reference                                                                                                                         Reference           
    Once                           759     1.45 (0.95--2.21)      0.08                                                                        1.36 (0.89--2.08)                                                       0.16                                                      1.31 (0.84--2.05)   0.23
    2--3 times/\>3 times           326     2.07 (1.25--3.41)      \<0.01^[\*\*](#tfn7-prm-19-e139){ref-type="table-fn"}^                      1.85 (1.20--3.07)                                                       0.02^[\*](#tfn6-prm-19-e139){ref-type="table-fn"}^        1.81 (1.07--3.07)   0.03^[\*](#tfn6-prm-19-e139){ref-type="table-fn"}^
  Problems with hypersomnolence:                                                                                                                                                                                                                                                                    
    Never                          965     Reference                                                                                          Reference                                                                                                                         Reference           
    A little                       1294    0.72 (0.48--1.08)      0.11                                                                        0.67 (0.44--1.01)                                                       0.06                                                      0.60 (0.39--0.91)   0.02^[\*](#tfn6-prm-19-e139){ref-type="table-fn"}^
    More than a little             174     0.90 (0.42--1.94)      0.79                                                                        0.83 (0.38--1.78)                                                       0.63                                                      0.67 (0.30--1.53)   0.34
    Big/very big                   60      4.20 (2.05--8.57)      \<0.001^[\*\*](#tfn7-prm-19-e139){ref-type="table-fn"}^                     3.79 (1.84--7.80)                                                       \<0.001^[\*\*](#tfn7-prm-19-e139){ref-type="table-fn"}^   3.42 (1.62--7.22)   \<0.001^[\*\*](#tfn7-prm-19-e139){ref-type="table-fn"}^
  Enough sleep:                                                                                                                                                                                                                                                                                     
    Always                         269     Reference                                                                                          Reference                                                                                                                         Reference           
    Usually                        1301    2.01 (0.86--4.71)      0.11                                                                        1.90 (0.81--4.48)                                                       0.14                                                      1.76 (0.74--4.17)   0.20
    Sometimes                      648     2.13 (0.88--5.17)      0.10                                                                        1.94 (0.79--4.75)                                                       0.15                                                      1.81 (0.74--4.47)   0.20
    Rarely/never                   275     4.00 (1.60--9.98)      \<0.01^[\*\*](#tfn7-prm-19-e139){ref-type="table-fn"}^                      3.67 (1.46--9.24)                                                       \<0.01^[\*\*](#tfn7-prm-19-e139){ref-type="table-fn"}^    3.04 (1.18--7.79)   0.02^[\*](#tfn6-prm-19-e139){ref-type="table-fn"}^

Adjusted for sex, ethnicity and socioeconomic position,

Additionally adjusted for depression (age 15) and current sleep problems (age 17).

P\<0.05;

P\<0.01;

P\<0.001

###### 

Associations between different forms of sleep problems at 15 years of age and the development of chronic widespread pain at 17 years of age

  **Types of sleep disturbance**   **n**   **Unadjusted model**   **Partially adjusted model^[†](#tfn9-prm-19-e139){ref-type="table-fn"}^**   **Fully adjusted model^[‡](#tfn10-prm-19-e139){ref-type="table-fn"}^**                                                                                 
  -------------------------------- ------- ---------------------- --------------------------------------------------------------------------- ------------------------------------------------------------------------ --------------------------------------------------------- ------------------- ---------------------------------------------------------
  Do you consider yourself a:                                                                                                                                                                                                                                                                        
    Good sleeper                   2114    Reference                                                                                          Reference                                                                                                                          Reference           
    Poor sleeper                   379     1.89 (1.19--3.02)      \<0.01^[\*\*](#tfn12-prm-19-e139){ref-type="table-fn"}^                     1.81 (1.13--2.89)                                                        0.01^[\*](#tfn11-prm-19-e139){ref-type="table-fn"}^       1.77 (1.07--2.91)   0.03^[\*](#tfn11-prm-19-e139){ref-type="table-fn"}^
  Usually wakes up:                                                                                                                                                                                                                                                                                  
    Never                          1408    Reference                                                                                          Reference                                                                                                                          Reference           
    Once                           759     1.71 (1.09--2.69)      0.02^[\*](#tfn11-prm-19-e139){ref-type="table-fn"}^                         1.58 (1.00--2.49)                                                        0.05                                                      1.54 (0.96--2.47)   0.07
    2--3 times/\>3 times           326     2.53 (1.50--4.28)      \<0.001^[\*\*\*](#tfn13-prm-19-e139){ref-type="table-fn"}^                  2.23 (1.31--3.80)                                                        \<0.01^[\*\*](#tfn12-prm-19-e139){ref-type="table-fn"}^   2.13 (1.22--3.74)   \<0.01^[\*\*](#tfn12-prm-19-e139){ref-type="table-fn"}^
  Problems with hypersomnolence:                                                                                                                                                                                                                                                                     
    Never                          965     Reference                                                                                          Reference                                                                                                                          Reference           
    A little                       1294    1.19 (0.75--1.87)      0.45                                                                        1.11 (0.70--1.76)                                                        0.66                                                      1.04 (0.65--1.67)   0.86
    More than a little             174     2.84 (1.50--5.38)      \<0.001^[\*\*\*](#tfn13-prm-19-e139){ref-type="table-fn"}^                  2.57 (1.35--4.90)                                                        \<0.01^[\*\*](#tfn12-prm-19-e139){ref-type="table-fn"}^   2.32 (1.18--4.54)   0.01^[\*](#tfn11-prm-19-e139){ref-type="table-fn"}^
    Big/very big                   60      3.35 (1.34--8.37)      0.01^[\*](#tfn11-prm-19-e139){ref-type="table-fn"}^                         3.01 (1.20--7.59)                                                        0.02^[\*](#tfn11-prm-19-e139){ref-type="table-fn"}^       2.76 (1.05--7.25)   0.04^[\*](#tfn11-prm-19-e139){ref-type="table-fn"}^
  Enough sleep:                                                                                                                                                                                                                                                                                      
    Always                         269     Reference                                                                                          Reference                                                                                                                          Reference           
    Usually                        1301    0.73 (0.38--1.41)      0.35                                                                        0.66 (0.34--1.34)                                                        0.22                                                      0.63 (0.32--1.23)   0.18
    Sometimes                      648     0.90 (0.44--1.80)      0.76                                                                        0.78 (0.38--1.58)                                                        0.49                                                      0.75 (0.37--1.52)   0.42
    Rarely/never                   275     1.68 (1.68--3.51)      0.17                                                                        1.46 (0.69--3.07)                                                        0.32                                                      1.20 (0.55--2.62)   0.64

Adjusted for sex, ethnicity and socioeconomic position;

Additionally adjusted for depression (15 years of age) and current sleep problems (17 years of age).

P\<0.05;

P\<0.01;

P\<0.001
